SNI:Neuro-Oncology 2015, Vol 6, Suppl I – A supplement to Surgical Neurology International
Growth kinetics from NOD SCID mice and Balb/c nude mice are available.
On April 8, 2021, the clinical trial application of HG381 for injection, developed by HitGen, wasRead More
#Medicilon will exhibit the 2021 AACR Virtual Annual Meeting from April 10-15. Please visit our virtualRead More
Livzon Pharmaceutical Group Inc. (Livzon) obtained a “novel coronavirus recombinant protein vaccine” (V-01) clinical trial approvalRead More
Medicilon will exhibit the 2021 SOT Virtual Annual Meeting from March 12-26. Please visit our virtualRead More
Jan 29th, 2021 – CDE announced that the innovative drug, 3D011-08 from 3D Medicines, was approvedRead More
Jan.27, 2021 – Xuanzhu Biotech announced that their XZP-5610, a new treatment for NASH (non-alcoholic steatohepatitis),Read More
Let's Start the Conversation
Shanghai Medicilon Inc.
Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China